Clinical Trial

Acute Effects of Maximal Exercise on Balance and Cognitive Domains in Young Men

Completed
View on ClinicalTrials.gov →
Summary
The project involves conducting a series of motor, physiological, biochemical, and psychological tests. The series of tests within the experiment will assess the effect of a single aerobic exercise (graded test) on changes in sensory organization and balance performance (based on the SOT test conducted on the Smart Balancemaster dynamic computerized posturography platform from Neurocom, USA) as well as cognitive functions in the Go/No-Go and Stroop tasks. Research Design: The study will be conducted in two rounds, each repeating the following design. Participants from both groups will complete cognitive tests, including the SOT sensory organization test. The first group will then undergo exercise (graded test), followed by a repeat of the SOT and cognitive tests. The second group will complete only the repeated SOT and cognitive tests. In the second round of testing, the design will be reversed for the groups. In groups that will perform the exercise test in a given series, blood will be collected three times to assess lactate concentration. The aim of the experiments will be to answer the fundamental question: To what extent do external factors disrupt or modify the sensory organization of balance and the efficiency of this process? What impact can cognitive impairments have on this process? Achieving this goal will require answering a number of specific questions: * To what extent does aerobic exercise affect sensory organization and the efficiency of balance? * To what extent does aerobic exercise affect cognitive functions, and to what extent does impairment in these functions affect sensory organization and the efficiency of balance?
Trial Details
NCT Number NCT07453043
Lead Sponsor University School of Physical Education, Krakow, Poland
Conditions Basic Science
Enrollment 30 participants
Start Date 2024-11-20
Primary Completion 2025-01-09 (estimated)
Study Completion 2025-01-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-05